CPC Biotech announced its official launch, bringing together the connector innovation of CPC and the flow control expertise of PSG Biotech to create a new fluid management component portfolio.
Operating under the CPC Biotech brand as part of PSG, a Dover company, the combined entity offers biopharma manufacturers a single source for sterile connectors, low-shear pumps and flow meters and sensors. The new entity’s solutions can support a wide range of bioprocessing applications, spanning the entire upstream and downstream biologic drug manufacturing process, as well as the cell and gene therapy manufacturing process. Products will be manufactured across facilities in North America, Europe and Asia.
CPC Biotech will make its public debut at INTERPHEX 2026.
Subscribe to our e-Newsletters
Stay up to date with news, articles and insights relevant to cell and gene therapy development and manufacturing. Plus, get special offers from Cell & Gene Therapy Review delivered right to your inbox!
Sign up now!